NCT05547984 Ceramic Modular Dual Mobility in Primary Total Hip Arthroplasty (THA)
| NCT ID | NCT05547984 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Aesculap AG |
| Condition | Coxarthrosis; Primary |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2022-11-21 |
| Primary Completion | 2027-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2022-11-21 with a primary completion date of 2027-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A randomized controlled trial comparing modular dual mobility inserts with ceramic multilayer coating versus standard polyethylene inserts for primary THA in a cementless acetabular cup
Eligibility Criteria
Inclusion Criteria: * Primary coxarthrosis patients indicated for cementless total hip arthroplasty * Written informed patient consent Exclusion Criteria: * Hip trauma or revision surgery * Rheumatoid or neurologic disease * BMI \>35 * Ongoing oncologic therapy * Preoperatively elevated Co or Cr serum levels \>1.0 µg/L * Patients with other joint implants, or anticipated need for another joint replacement surgery within the study period * Acetabular cup size \<52 expected * Patients not able to mentally or physically comply with the study demands and follow-up visits * Patients \<18 years at surgery * Pregnancy
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05547984 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Coxarthrosis; Primary. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05547984 currently recruiting?
Yes, NCT05547984 is actively recruiting participants. Contact the research team at info@aesculap.de for enrollment information.
Where is the NCT05547984 trial being conducted?
This trial is being conducted at Ústí nad Labem, Czechia.
Who is sponsoring the NCT05547984 clinical trial?
NCT05547984 is sponsored by Aesculap AG. The trial plans to enroll 100 participants.